169 related articles for article (PubMed ID: 2582119)
1. Chemotherapy for non-seminomatous germ-cell tumours.
Wilkinson PM
J R Soc Med; 1985; 78 Suppl 6(Suppl 6):43-7. PubMed ID: 2582119
[No Abstract] [Full Text] [Related]
2. Improving the outcome of salvage treatment for non-seminomatous germ cell tumours (NSGCT).
de Bono JS; Paul J; Simpson A; Anthoney A; Kirk D; Underwood M; Graham J; Kaye SB
Br J Cancer; 2000 Aug; 83(4):426-30. PubMed ID: 10945485
[TBL] [Abstract][Full Text] [Related]
3. Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours.
Fizazi K; Prow DM; Do KA; Wang X; Finn L; Kim J; Daliani D; Papandreou CN; Tu SM; Millikan RE; Pagliaro LC; Logothetis CJ; Amato RJ
Br J Cancer; 2002 May; 86(10):1555-60. PubMed ID: 12085204
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy for poor risk germ cell tumours. An independent evaluation of the POMB/ACE regime.
Cullen MH; Harper PG; Woodroffe CM; Kirkbride P; Clarke J
Br J Urol; 1988 Nov; 62(5):454-60. PubMed ID: 2463034
[TBL] [Abstract][Full Text] [Related]
5. Studies of the Australasian Germ Cell Trial Group: the management of advanced testis cancer.
Raghavan D; Levi J; Thomson D; Harvey V
Prog Clin Biol Res; 1990; 350():319-29. PubMed ID: 1696742
[No Abstract] [Full Text] [Related]
6. [Combination chemotherapy with POMB/ACE (cisplatin, vincristine, methotrexate, bleomycin, actinomycin D, cyclophosphamide, etoposide) in advanced non-seminomatous testicular tumor].
Masuda F; Kawahara M; Asano K; Shirakawa H
Gan To Kagaku Ryoho; 1995 Oct; 22(12):1847-50. PubMed ID: 7574821
[TBL] [Abstract][Full Text] [Related]
7. Ovarian germ cell malignancies: the Yale University experience.
Schwartz PE; Chambers SK; Chambers JT; Kohorn E; McIntosh S
Gynecol Oncol; 1992 Apr; 45(1):26-31. PubMed ID: 1376294
[No Abstract] [Full Text] [Related]
8. POMB/ACE chemotherapy in non-seminomatous germ cell tumours: outcome and importance of dose intensity.
Husband DJ; Green JA
Eur J Cancer; 1992; 28(1):86-91. PubMed ID: 1373636
[TBL] [Abstract][Full Text] [Related]
9. The long-term outcome of patients who relapse after chemotherapy for non-seminomatous germ cell tumours.
Ledermann JA; Holden L; Newlands ES; Begent RH; Rustin GJ; Bagshawe KD; Brampton M
Br J Urol; 1994 Aug; 74(2):225-30. PubMed ID: 7522874
[TBL] [Abstract][Full Text] [Related]
10. [Chemotherapeutic effectiveness in malignant testicular tumors at advanced stages. Preliminary results of the VAB VI program].
Chiricuţă I; Ghilezan N
Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1985; 34(6):455-68. PubMed ID: 2421373
[No Abstract] [Full Text] [Related]
11. The management of advanced testicular teratoma.
Peckham MJ; Horwich A; Easton DF; Hendry WF
Br J Urol; 1988 Jul; 62(1):63-8. PubMed ID: 2457402
[TBL] [Abstract][Full Text] [Related]
12. Treatment of men with metastatic non-seminomatous germ cell tumours with cyclical POMB/ACE chemotherapy.
Bower M; Newlands ES; Holden L; Rustin GJ; Begent RH
Ann Oncol; 1997 May; 8(5):477-83. PubMed ID: 9233528
[TBL] [Abstract][Full Text] [Related]
13. Combination chemotherapy for immature (malignant) teratomas of the ovary.
Singh P; Yordan EL; Graham JR; Wilbanks GD; Slayton RE; Miller AW; Ratnam SS
Asia Oceania J Obstet Gynaecol; 1987 Dec; 13(4):455-9. PubMed ID: 2447859
[No Abstract] [Full Text] [Related]
14. Treatment of patients with poor prognosis anaplastic germ cell tumours (AGCT) of the testis and other sites.
Newlands ES; Bagshawe KD; Begent RH; Rustin GJ; Crawford SM; Holden L
Int J Androl; 1987 Feb; 10(1):301-9. PubMed ID: 2438223
[TBL] [Abstract][Full Text] [Related]
15. POMB/ACE chemotherapy for mediastinal germ-cell tumours.
Droz JP
Eur J Cancer; 1997 May; 33(6):809-11. PubMed ID: 9291797
[No Abstract] [Full Text] [Related]
16. Successful management of metastatic and primary germ cell tumors in the brain.
Rustin GJ; Newlands ES; Bagshawe KD; Begent RH; Crawford SM
Cancer; 1986 Jun; 57(11):2108-13. PubMed ID: 2421864
[TBL] [Abstract][Full Text] [Related]
17. [Primary testicular tumors in children].
Beresi V; del Pozo H; Quintana J; Latorre JJ; Izzo C
Rev Chil Pediatr; 1987; 58(1):69-73. PubMed ID: 2450388
[No Abstract] [Full Text] [Related]
18. Evaluation of primary standard cisplatin-based chemotherapy for clinical stage II non-seminomatous germ cell tumours of the testis.
Culine S; Theodore C; Court BH; Perrin JL; Droz JP
Br J Urol; 1997 Feb; 79(2):258-62. PubMed ID: 9052479
[TBL] [Abstract][Full Text] [Related]
19. [Combination chemotherapy with bleomycin, vincristine and methotrexate for stage I non-seminomatous germ cell testicular tumors].
Fukui I; Yokokawa M; Wakui M; Washizuka M; Katoh M; Igarashi K; Takeuchi S; Gotoh S; Afuso H; Tachibana Y
Hinyokika Kiyo; 1983 Feb; 29(2):191-8. PubMed ID: 6203379
[TBL] [Abstract][Full Text] [Related]
20. Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum for advanced germ cell testis tumors: Brazilian experience.
Srougi M; Simon SD; de Góes GM
J Urol; 1985 Jul; 134(1):65-9. PubMed ID: 2409300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
